Whitehawk Expands ADC Cancer Therapy Pipeline
MORRISTOWN, N.J., May 21, 2026 Whitehawk Therapeutics has announced a major expansion of its antibody-drug conjugate (ADC) oncology pipeline...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MORRISTOWN, N.J., May 21, 2026 Whitehawk Therapeutics has announced a major expansion of its antibody-drug conjugate (ADC) oncology pipeline...
GALWAY, Ireland, May 20, 2026 Medtronic plc has announced its intent to acquire SPR Therapeutics, Inc. in a deal...
VANCOUVER, British Columbia, May 20, 2026 Optimi Health Corp. has announced the pricing of an oversubscribed US$15 million underwritten...
BOSTON, Mass., May 20, 2026 The Paragon Institute has released a new scientific proposal highlighting the growing risks associated...
JERUSALEM, May 15, 2026 Scinai Immunotherapeutics announced that its leadership team will lead a strategic roundtable discussion at the...
BIRMINGHAM, Ala., and SAN DIEGO, Calif., May 15, 2026 Guideway Care announced the appointment of nationally recognized healthcare and...
PALO ALTO, Calif., May 14, 2026 Glooko, Inc. announced that the U.S. Food and Drug Administration has granted 510(k)...
SUNNYVALE, Calif., May 13, 2026 Cepheid, a Danaher company, announced that it has received CE marking under the European...
NEW YORK, May 13, 2026 Pfizer has received European Commission approval for HYMPAVZI® (marstacimab) for the treatment of adults...
JERSEY CITY, N.J. and OR YEHUDA, Israel, May 11, 2026 Exero Medical has announced positive pivotal clinical study results...
